Source: International Congress 2015 – New insights into IIPs
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Martina Vašáková (Prague, Czech Republic), Martina Vasakova, Martina Sterclova, Peter Paluch, Veronika Polcova, Radoslav Matej, Jelena Skibova. Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?. Eur Respir J 2015; 46: Suppl. 59, 4850

Member's Comments

No comment yet.

Related content which might interest you: Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 What does bronchoalveolar lavage add to cryobiopsy in interstitial lung disease? Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases Source: International Congress 2016 – Connective tissue disorders Year: 2016 Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Characterization of inflammation in bronchoalveolar lavage of lung transplant patients Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease Source: Eur Respir Rev 2010 19: 237-241 Year: 2010 Bronchoalveolar lavage in interstitial lung disease associated with collagen vascular disorders Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases Source: Eur Respir Mon; 2009: 46: 36–46 Year: 2009 Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease Source: ERJ Open Res, 8 (1) 00481-2021; 10.1183/23120541.00481-2021 Year: 2022 Interstitial lung disease profiling by mean of broncho-alveolar lavage Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Bronchoalveolar lavage Source: Eur Respir Mon; 2010: 48: 59–72 Year: 2010 Cytofluorimetric BAL cells characterization in IPF and in other ILD Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Eosinophilic lung disease Source: International Congress 2016 – Orphan diseases I Year: 2016 Inflammatory proteins in bronchoalveolar lavage of lung transplanted patients Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009 Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015